Brain-Responsive device aims to quiet seizures

NCT ID NCT06424977

Not yet recruiting Disease control Sponsor: Cadence Neuroscience Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device that reads brain signals and delivers targeted electrical stimulation to reduce seizures in people with epilepsy. The device aims to calm overactive brain areas before a seizure starts. Researchers will monitor safety and track seizure frequency in 40 participants aged 7 and older.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Biomarker Targeted Stimulation (BTS) device
What this could lead to: If it works, this could offer a new way to control seizures by automatically adjusting brain stimulation based on real-time signals.
What could go wrong: This is an early study with only 40 people, so results may not apply to everyone. The device is new, and its safety and effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.